Back

HFWM: Circulating relaxin-1 is a surrogate marker of myocardial fibrosis and left ventricular diastolic function in HFrEF

26 May 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Basic science - Cardiomyopathies Biomarkers HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Edit Gara

Semmelweis University, Budapest (Hungary)

20 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor N. Bomer (Groningen, NL)
Abstract
Presentation thumbnail
Doctor N. Pavlaki (Hamburg, DE)
Abstract
Presentation thumbnail
Doctor B. Kozlowska (Warsaw, PL)
Abstract
Presentation thumbnail
Doctor P. Bengel (Giessen, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Basic science - Cardiomyopathies

The Event

Event poster

Heart Failure 2019

26 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
The anti-arrhythmic properties of relaxin in heart failure with preserved ejection fraction
21 May 2023
thumbnail
Congress Presentation
Significant correlation between the extent of myocardial fibrosis and heart failure parameters in patients undergoing transcatheter aortic valve implantation.
2 September 2024
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025
thumbnail
Congress Presentation
18-month pattern of cardiac-specific biomarkers and replacement and interstitial fibrosis in dilated cardiomyopathy
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources